In Jena, functional and innovative pharmaceutical polymers for novel drug formulations for the treatment of infectious diseases by targeted modulation of the immune response are being developed. Our group is also part of the great consortium. The developed platform technology will help in preparing for future infections and pandemics as well as overcoming allergic side effects of existing and future drugs and vaccines.